The J-Valve System is associated with positive 10-year outcomes for patients with severe AR, according to new research out of China. It also performs well in patients with severe AS.
SCAI has shared a new call to action as an observance of American Heart Month. The group is asking Congress to pass new pieces of legislation that could improve care for PAD patients and get important medical devices in the hands of interventional cardiologists.
The Magnolia, Texas, firm has seen rapid growth in recent years, being named to the Deloitte Technology Fast 500 in 2024 after logging revenue growth of 212% over a three-year period.
Sens. Tim Kaine, D-Va., and John Boozman, R-Ark., have introduced legislation to lift "arbitrary" caps on compensation for therapeutic and diagnostic medical physicists working in the VA.
Siemens self-reported a problem with software being inadvertently delivered to U.S. systems when the applications have not yet been cleared for use by the FDA.
Discounts represent out-of-pocket costs and come in the form of direct-to-consumer sales through manufacturer websites or via a coupon. AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer have all listed some of their most popular drugs on the TrumpRx.gov portal.
The more persuasive of the opinions could redound to the reshaping of the principles of pediatric medicine—and of certain policies in public education. Here’s a sampling.
New Jersey-based Zydus Pharmaceuticals has recalled nearly 23,000 bottles of its icosapent ethyl capsules due to leakage issues that may have weakened their effectiveness.
The J-Valve System is associated with positive 10-year outcomes for patients with severe AR, according to new research out of China. It also performs well in patients with severe AS.
